1. 00080 PITFALLS OF SENTINEL NODE IDENTIFICATION IN MIDLINE VULVAR CANCER. (1st September 2005) Authors: Louis-Sylvestre, C.; Leonard, F; Evangelista, E.; Itti, E.; Meignan, M.; Paniel, B. J. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BASELINE CIRCULATING CELL‐FREE DNA LOAD IS RELATED TO, BUT ADDS PROGNOSTIC VALUE TO METABOLIC TUMOR BURDEN MEASURED BY FDG PET/CT IN FOLLICULAR LYMPHOMA. (June 2017) Authors: Delfau‐Larue, M.H.; Benmaad, I.; Robert, P.; Hamdane, S.; Nel, I.; Dupuis, J.; Haioun, C.; Berriolo Riedinger, A.; Casasnovas, R.O.; Itti, E. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CLINICAL, IMMUNOPHENOTYPIC AND GENETIC CHARACTERISTICS OF AGGRESSIVE (NON‐BURKITT) B‐CELL LYMPHOMA IN A REAL LIFE COHORT. (12th June 2019) Authors: Roulin, L.; Jais, J.; Poullot, E.; Robe, C.; Scherman, E.; Lemonnier, F.; Le Bras, F.; Maarek, A.; Belhadj, K.; Dupuis, J.; Hammoud, M.; El Gnaoui, T.; Mule, S.; Itti, E.; Delfau‐Larue, M.; Gaulard, P.; Haioun, C.; Copie‐Bergman, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dual-tracer 18F-fluorocholine and 18F-fluorodeoxyglucose PET/CT for the diagnosis of tumoral portal vein thrombosis in patients with hepatocellular carcinoma. (April 2016) Authors: Chalaye, J.; Baranes, L.; Costentin, C.; Lim, C.; Herin, E.; Calderaro, J.; Rahmouni, A.; Azoulay, D.; Itti, E.; Luciani, A. Journal: HPB Issue: Volume 18(2016)Supplement 1 Page Start: e531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. High‐dose transdermal nicotine in Parkinson's disease patients: a randomized, open‐label, blinded‐endpoint evaluation phase 2 study. (23rd October 2017) Authors: Villafane, G.; Thiriez, C.; Audureau, E.; Straczek, C.; Kerschen, P.; Cormier‐Dequaire, F.; Van Der Gucht, A.; Gurruchaga, J.‐M.; Quéré‐Carne, M.; Evangelista, E.; Paul, M.; Defer, G.; Damier, P.; Remy, P.; Itti, E.; Fénelon, G. Journal: European journal of neurology Issue: Volume 25:Number 1(2018) Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN (R‐GemOx) IN REFRACTORY/RELAPSED (R/R) DLBCL. A REAL LIFE STUDY IN PATIENTS INELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION. (12th June 2019) Authors: Cazelles, C.; Belhadj, K.; Vellemans, H.; Camus, V.; Copi‐Bergman, C.; Veresezan, L.; Itti, E.; Becker, S.; Carvalho, M.; Dupuis, J.; Fabien, L.; Lemonnier, F.; Roulin, L.; El Gnaoui, T.; Jardin, F.; Mounier, N.; Tilly, H.; Haioun, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗